OccuLogix drives on with US hopes for age-related macular degeneration filter
This article was originally published in Clinica
Executive Summary
Following a major setback in its plans to take to the US its blood filter system for treating dry age-related macular degeneration (AMD), OccuLogix is to conduct an additional trial of the device.